Filing Details

Accession Number:
0001140361-14-041393
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-12 19:09:58
Reporting Period:
2014-11-10
Filing Date:
2014-11-12
Accepted Time:
2014-11-12 19:09:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197355 J Henry Fuchs C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-10 20,000 $21.51 96,550 No 4 M Direct
Common Stock Disposition 2014-11-10 20,000 $86.55 76,550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2014-11-10 20,000 $0.00 20,000 $21.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,155 2010-11-12 2020-05-11 No 4 M Direct
Footnotes
  1. The price in column 4 is a weighted average price. The price actually received ranged from $86.65 to $86.44. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Options vest 6/48ths on November 12, 2010 and 1/48th on the 12th of each month thereafter.
  3. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.